Skip to content

Role of Mahatiktaka Ghrita and its ointment in the management of Eczema.

Pharmaceutical standardization of Mahatiktaka Ghrita & its comparative clinical study with external application in the management of Vicharchika (Eczema)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052227
Enrollment
60
Registered
2023-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Sponsors

Institute of teaching and research in Ayurveda, Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Both the sexes having age between 18 to 60 years 2)Patient having classical signs and symptoms of Vicharchika like Kandu, Vaivarnyata and eczema. 3)Uncomplicated cases with classical signs and symptoms of Vicharchika will be selected irrespective of gender, religion, profession.

Exclusion criteria

Exclusion criteria: 1)Age below 18yrs and above 60yrs. 2)Pregnant women 3)Lactating mother. 4)Uncontrolled Diabetes Mellitus & Hypertension 5)Any other serious systemic illness 6)Patients who are not willing for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Assessment of efficacy of Mahatiktaka Ghrita internally and its external application of its ointment in the management of Vicharchika (eczema) through EASI score PNS score, ESR and cardinal features of disease.Timepoint: 6 Weeks

Secondary

MeasureTime frame
persistence of improvement in cardinal signs and symptoms, EASI score, PNS score of Eczema, ESR after 4 weeks of follow up after administration of 6 weeks intervention that is persistence of effect even after 4 weeks without any treatment.Timepoint: 0,6, 10 Weeks

Countries

India

Contacts

Public ContactProf BJ patgiri

Institute of Teaching and Research in Ayurveda, Jamnagar

patgiri124@gmail.com9426947438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026